Recombinant multi-species CPSF4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CPSF4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Inhibition of the nuclear export of poly(A)-containing mRNAs caused by the influenza A virus NS1 protein requires its effector domain. The NS1 effector domain functionally interacts with the cellular 30 kDa subunit of cleavage and polyadenylation specific factor 4, an essential component of the 3' end processing machinery of cellular pre-mRNAs. In influenza virus-infected cells, the NS1 protein is physically associated with cleavage and polyadenylation specific factor 4, 30kD subunit. Binding of the NS1 protein to the 30 kDa protein in vitro prevents CPSF binding to the RNA substrate and inhibits 3' end cleavage and polyadenylation of host pre-mRNAs. Thus the NS1 protein selectively inhibits the nuclear export of cellular, and not viral, mRNAs. Multiple alternatively spliced transcript variants that encode different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 30kDa,CPSF30,CPSF4,Cleavage and polyadenylation specificity factor 30 kDa subunit (CPSF 30 kDa subunit),Cleavage and polyadenylation specificity factor subunit 4,Cpsf4,NAR,NEB-1,NEB1,NS1 effector domain-binding protein 1 (Neb-1),No arches homolog
Go
to CPSF4 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP3847-Ag-1/ GM-Tg-hg-IP3847-Ag-2 | Human CPSF4 protein | Human |
| GM-Tg-rg-IP3847-Ag-1/ GM-Tg-rg-IP3847-Ag-2 | Rat CPSF4 protein | Rat |
| GM-Tg-mg-IP3847-Ag-1/ GM-Tg-mg-IP3847-Ag-2 | Mouse CPSF4 protein | Mouse |
| GM-Tg-cynog-IP3847-Ag-1/ GM-Tg-cynog-IP3847-Ag-2 | Cynomolgus/Rhesus macaque CPSF4 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP3847-Ag-1/ GM-Tg-felg-IP3847-Ag-2 | Feline CPSF4 protein | Feline |
| GM-Tg-cang-IP3847-Ag-1/ GM-Tg-cang-IP3847-Ag-2 | Canine CPSF4 protein | Canine |
| GM-Tg-bovg-IP3847-Ag-1/ GM-Tg-bovg-IP3847-Ag-2 | Bovine CPSF4 protein | Bovine |
| GM-Tg-equg-IP3847-Ag-1/ GM-Tg-equg-IP3847-Ag-2 | Equine CPSF4 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP3847-Ag-1/ GM-Tg-hg-IP3847-Ag-2;
GM-Tg-rg-IP3847-Ag-1/ GM-Tg-rg-IP3847-Ag-2;
GM-Tg-mg-IP3847-Ag-1/ GM-Tg-mg-IP3847-Ag-2; GM-Tg-cynog-IP3847-Ag-1/ GM-Tg-cynog-IP3847-Ag-2; GM-Tg-felg-IP3847-Ag-1/ GM-Tg-felg-IP3847-Ag-2; GM-Tg-cang-IP3847-Ag-1/ GM-Tg-cang-IP3847-Ag-2; GM-Tg-bovg-IP3847-Ag-1/ GM-Tg-bovg-IP3847-Ag-2; GM-Tg-equg-IP3847-Ag-1/ GM-Tg-equg-IP3847-Ag-2 |
| Products Name | CPSF4 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | CPSF4 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CPSF4 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.